Melanoma

Daniel G. Coit, Robert Andtbacka, Christopher K. Bichakjian, Raza A. Dilawari, Dominick J DiMaio, Valerie Guild, Allan C. Halpern, F. Stephen Hodi, Mohammed Kashani-Sabet, Julie R. Lange, Anne Lind, Lainie Martin, Mary C. Martini, Scott K. Pruitt, Merrick I. Ross, Stephen F. Sener, Susan M. Swetter, Kenneth K. Tanabe, John A. Thompson, Vijay TrisalMarshall M. Urist, Jeffrey Weber, Michael K. Wong

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

These guidelines represent an effort to distill and simplify an enormous body of knowledge and experience into fairly simple management algorithms. In general, treatment recommendations for primary tumors are based on better data than the recommendations for treating recurrent disease. Few, if any, firm recommendations can be made about more controversial issues for melanoma patients, such as the extent of workup or intensity of follow-up. These guidelines are intended as a point of departure, recognizing that all clinical decisions about individual patient management must be tempered by the clinician's judgment and other factors, such as local resources and expertise, and the individual patient's needs, wishes, and expectations. Furthermore, these guidelines are revised annually and continually as new data become available.

Original languageEnglish (US)
Pages (from-to)250-275
Number of pages26
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Melanoma
Guidelines
Neoplasms
Therapeutics

Keywords

  • Adjuvant therapy
  • Biopsy
  • Chemotherapy
  • Interferon
  • Lymph node dissection
  • Margin
  • Melanoma
  • Metastases
  • NCCN Clinical Practice Guidelines
  • Pathology
  • Radiation therapy
  • Sentinel lymph node
  • Skin cancer
  • Surgical excision

ASJC Scopus subject areas

  • Oncology

Cite this

Coit, D. G., Andtbacka, R., Bichakjian, C. K., Dilawari, R. A., DiMaio, D. J., Guild, V., ... Wong, M. K. (2009). Melanoma. JNCCN Journal of the National Comprehensive Cancer Network, 7(3), 250-275. https://doi.org/10.6004/jnccn.2009.0020

Melanoma. / Coit, Daniel G.; Andtbacka, Robert; Bichakjian, Christopher K.; Dilawari, Raza A.; DiMaio, Dominick J; Guild, Valerie; Halpern, Allan C.; Hodi, F. Stephen; Kashani-Sabet, Mohammed; Lange, Julie R.; Lind, Anne; Martin, Lainie; Martini, Mary C.; Pruitt, Scott K.; Ross, Merrick I.; Sener, Stephen F.; Swetter, Susan M.; Tanabe, Kenneth K.; Thompson, John A.; Trisal, Vijay; Urist, Marshall M.; Weber, Jeffrey; Wong, Michael K.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 7, No. 3, 03.2009, p. 250-275.

Research output: Contribution to journalArticle

Coit, DG, Andtbacka, R, Bichakjian, CK, Dilawari, RA, DiMaio, DJ, Guild, V, Halpern, AC, Hodi, FS, Kashani-Sabet, M, Lange, JR, Lind, A, Martin, L, Martini, MC, Pruitt, SK, Ross, MI, Sener, SF, Swetter, SM, Tanabe, KK, Thompson, JA, Trisal, V, Urist, MM, Weber, J & Wong, MK 2009, 'Melanoma', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 3, pp. 250-275. https://doi.org/10.6004/jnccn.2009.0020
Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, DiMaio DJ, Guild V et al. Melanoma. JNCCN Journal of the National Comprehensive Cancer Network. 2009 Mar;7(3):250-275. https://doi.org/10.6004/jnccn.2009.0020
Coit, Daniel G. ; Andtbacka, Robert ; Bichakjian, Christopher K. ; Dilawari, Raza A. ; DiMaio, Dominick J ; Guild, Valerie ; Halpern, Allan C. ; Hodi, F. Stephen ; Kashani-Sabet, Mohammed ; Lange, Julie R. ; Lind, Anne ; Martin, Lainie ; Martini, Mary C. ; Pruitt, Scott K. ; Ross, Merrick I. ; Sener, Stephen F. ; Swetter, Susan M. ; Tanabe, Kenneth K. ; Thompson, John A. ; Trisal, Vijay ; Urist, Marshall M. ; Weber, Jeffrey ; Wong, Michael K. / Melanoma. In: JNCCN Journal of the National Comprehensive Cancer Network. 2009 ; Vol. 7, No. 3. pp. 250-275.
@article{c12380ec80e147f2a3270ffe72b70124,
title = "Melanoma",
abstract = "These guidelines represent an effort to distill and simplify an enormous body of knowledge and experience into fairly simple management algorithms. In general, treatment recommendations for primary tumors are based on better data than the recommendations for treating recurrent disease. Few, if any, firm recommendations can be made about more controversial issues for melanoma patients, such as the extent of workup or intensity of follow-up. These guidelines are intended as a point of departure, recognizing that all clinical decisions about individual patient management must be tempered by the clinician's judgment and other factors, such as local resources and expertise, and the individual patient's needs, wishes, and expectations. Furthermore, these guidelines are revised annually and continually as new data become available.",
keywords = "Adjuvant therapy, Biopsy, Chemotherapy, Interferon, Lymph node dissection, Margin, Melanoma, Metastases, NCCN Clinical Practice Guidelines, Pathology, Radiation therapy, Sentinel lymph node, Skin cancer, Surgical excision",
author = "Coit, {Daniel G.} and Robert Andtbacka and Bichakjian, {Christopher K.} and Dilawari, {Raza A.} and DiMaio, {Dominick J} and Valerie Guild and Halpern, {Allan C.} and Hodi, {F. Stephen} and Mohammed Kashani-Sabet and Lange, {Julie R.} and Anne Lind and Lainie Martin and Martini, {Mary C.} and Pruitt, {Scott K.} and Ross, {Merrick I.} and Sener, {Stephen F.} and Swetter, {Susan M.} and Tanabe, {Kenneth K.} and Thompson, {John A.} and Vijay Trisal and Urist, {Marshall M.} and Jeffrey Weber and Wong, {Michael K.}",
year = "2009",
month = "3",
doi = "10.6004/jnccn.2009.0020",
language = "English (US)",
volume = "7",
pages = "250--275",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "3",

}

TY - JOUR

T1 - Melanoma

AU - Coit, Daniel G.

AU - Andtbacka, Robert

AU - Bichakjian, Christopher K.

AU - Dilawari, Raza A.

AU - DiMaio, Dominick J

AU - Guild, Valerie

AU - Halpern, Allan C.

AU - Hodi, F. Stephen

AU - Kashani-Sabet, Mohammed

AU - Lange, Julie R.

AU - Lind, Anne

AU - Martin, Lainie

AU - Martini, Mary C.

AU - Pruitt, Scott K.

AU - Ross, Merrick I.

AU - Sener, Stephen F.

AU - Swetter, Susan M.

AU - Tanabe, Kenneth K.

AU - Thompson, John A.

AU - Trisal, Vijay

AU - Urist, Marshall M.

AU - Weber, Jeffrey

AU - Wong, Michael K.

PY - 2009/3

Y1 - 2009/3

N2 - These guidelines represent an effort to distill and simplify an enormous body of knowledge and experience into fairly simple management algorithms. In general, treatment recommendations for primary tumors are based on better data than the recommendations for treating recurrent disease. Few, if any, firm recommendations can be made about more controversial issues for melanoma patients, such as the extent of workup or intensity of follow-up. These guidelines are intended as a point of departure, recognizing that all clinical decisions about individual patient management must be tempered by the clinician's judgment and other factors, such as local resources and expertise, and the individual patient's needs, wishes, and expectations. Furthermore, these guidelines are revised annually and continually as new data become available.

AB - These guidelines represent an effort to distill and simplify an enormous body of knowledge and experience into fairly simple management algorithms. In general, treatment recommendations for primary tumors are based on better data than the recommendations for treating recurrent disease. Few, if any, firm recommendations can be made about more controversial issues for melanoma patients, such as the extent of workup or intensity of follow-up. These guidelines are intended as a point of departure, recognizing that all clinical decisions about individual patient management must be tempered by the clinician's judgment and other factors, such as local resources and expertise, and the individual patient's needs, wishes, and expectations. Furthermore, these guidelines are revised annually and continually as new data become available.

KW - Adjuvant therapy

KW - Biopsy

KW - Chemotherapy

KW - Interferon

KW - Lymph node dissection

KW - Margin

KW - Melanoma

KW - Metastases

KW - NCCN Clinical Practice Guidelines

KW - Pathology

KW - Radiation therapy

KW - Sentinel lymph node

KW - Skin cancer

KW - Surgical excision

UR - http://www.scopus.com/inward/record.url?scp=63449127290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63449127290&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2009.0020

DO - 10.6004/jnccn.2009.0020

M3 - Article

C2 - 19401060

AN - SCOPUS:63449127290

VL - 7

SP - 250

EP - 275

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 3

ER -